Group 1 - The company Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. is convening its second extraordinary general meeting of shareholders in 2025 on September 15, 2025, at 14:00 [1] - Shareholders registered with China Securities Depository and Clearing Corporation Limited Shenzhen Branch as of September 8, 2025, are entitled to attend the meeting or appoint a proxy to vote [2] - The meeting will review several proposals, including three special resolutions that require approval from more than two-thirds of the voting rights held by attending shareholders [4] Group 2 - The registration process for attending the meeting includes specific requirements for both corporate and individual shareholders, including necessary documentation [5][6] - Shareholders can participate in voting through both on-site and online platforms provided by the Shenzhen Stock Exchange, with detailed voting procedures outlined [10] - The company emphasizes that only one voting method can be chosen for each voting right, and duplicate votes will be disregarded, with the first vote counted as valid [10]
泓博医药: 关于召开2025年第二次临时股东大会通知公告